#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA655185	F	Cytotoxic conc. which reduces the cell viability of HIV-1 LAI infected T4 lymphoblastoid CEM-SS cells by 50%	Human immunodeficiency virus 1	2		cell-based format	Scientific Literature
2.	ALA655187	F	Cytotoxic concentration which reduces the cell viability of HIV-1 LAI infected T4 lymphoblastoid CEM-SS cells by 50%	Human immunodeficiency virus 1	25		cell-based format	Scientific Literature
3.	ALA655350	F	Effective concentration required to achieve 50% inhibition of HIV-1 LAI replication in human T4 lymphoblastoid CEM-SS cells.	Human immunodeficiency virus 1	27		cell-based format	Scientific Literature
4.	ALA659203	F	Effective concentration in vitro against HIV-1-infected CEM cells relative to uninfected untreated controls	Human immunodeficiency virus 1	12		cell-based format	Scientific Literature
5.	ALA659204	F	Effective concentration (in vitro anti-HIV activity ) which produces a 50% survival of HIV-1-infected CEM cells relative to uninfected untreated controls; Inactive	Human immunodeficiency virus 1	7		cell-based format	Scientific Literature
6.	ALA653877	F	Effective concentration required to inhibit HIV-1 induced cytopathicity by 50% in CEM cells	Human immunodeficiency virus 1	20		cell-based format	Scientific Literature
7.	ALA664383	B	Selective index is the ratio of inhibitory concentrations of cellular DNA polymerase delta to HIV-1 reverse transcriptase		1		single protein format	Scientific Literature
8.	ALA683627	F	Compound was evaluated for the antiviral activity against compound resistant virus isolate Y181C/K103N with amino acid changes in the HIV-1 reverse transcriptase (RT); ND means not determined		1		assay format	Scientific Literature
9.	ALA686035	F	Effective concentration required to inhibit HIV-1 induced cytopathicity in CEM cell culture by 50%.	Human immunodeficiency virus 1	21		cell-based format	Scientific Literature
10.	ALA686036	F	Effective concentration required to inhibit HIV-1 induced cytopathicity in MT-4 cell culture by 50%.	Human immunodeficiency virus 1	22		cell-based format	Scientific Literature
11.	ALA683867	F	Antiviral activity was evaluated against K103N mutant HIV-1 virus	Human immunodeficiency virus 1	25		assay format	Scientific Literature
12.	ALA690385	F	Compound was evaluated for its ability to inhibit a virus containing the clinically relevant K103N mutation	Human immunodeficiency virus 1	25		assay format	Scientific Literature
13.	ALA690386	F	Compound was evaluated for its ability to inhibit the wild type RF strain of HIV-1	Human immunodeficiency virus 1	25		assay format	Scientific Literature
14.	ALA694657	F	Tested in vitro against HIV-1 LAI from MT-4 cells using MTT assay	Human immunodeficiency virus 1	21		cell-based format	Scientific Literature
15.	ALA694660	F	Tested in vitro against HIV-1 MDR using MAGI assay	Human immunodeficiency virus 1	12		assay format	Scientific Literature
16.	ALA689897	B	Cross Resistance (antiviral activity) with 4xAZT (Non nucleoside reverse transcriptase inhibitor) resistant HIV isolate from cytopathic cell killing assay		4		single protein format	Scientific Literature
17.	ALA689898	B	Cross Resistance (antiviral activity) with 4xAZT/L100I (Non nucleoside reverse transcriptase inhibitor) resistant HIV isolate from cytopathic cell killing assay		4		single protein format	Scientific Literature
18.	ALA689899	B	Cross Resistance (antiviral activity) with 4xAZT/Y181C (Non nucleoside reverse transcriptase inhibitor) resistant HIV isolate from cytopathic cell killing assay		3		single protein format	Scientific Literature
19.	ALA693547	B	Cross Resistance (antiviral activity) with A98G (Non nucleoside reverse transcriptase inhibitor) resistant HIV isolate from cytopathic cell killing assay		3		single protein format	Scientific Literature
20.	ALA693548	B	Cross Resistance (antiviral activity) with K101E (Non nucleoside reverse transcriptase inhibitor) resistant HIV isolate from cytopathic cell killing assay		3		single protein format	Scientific Literature